Skip to main content
. Author manuscript; available in PMC: 2013 Mar 15.
Published in final edited form as: Methods Inf Med. 2012 Feb 20;51(2):152–161. doi: 10.3414/ME11-02-0019

Table IV.

Analysis of breast cancer prognosis studies. Gene: number of genes identified using different approaches; Overlap: number of overlapped genes with those identified with iSBoost; Corr: correlation coefficient between predictive risk scores and those with iSBoost.

Gene Overlap Corr Logrank
Meta-analysis Cox-SBoost 53 7 0.209 3.443
AFT-Enet 70 12 0.354 3.012
AFT-Boost 182 35 0.409 1.240
AFT-SBoost 69 17 0.387 4.578
Intensity approach Cox-SBoost 22 3 0.274 2.887
AFT-Enet 28 9 0.412 2.773
AFT-Boost 127 16 0.366 1.717
AFT-SBoost 20 4 0.447 2.570
Integrative analysis Cox-iSBoost 51 13 0.404 5.125
AFT-Enet 38 11 0.523 3.306
AFT-iBoost 117 31 0.679 2.290
AFT-iSBoost 44 -- -- 5.611